329923-08-2Relevant articles and documents
Bis-sulfonamides as endothelin receptor antagonists
Boss, Christoph,Bolli, Martin H.,Weller, Thomas,Fischli, Walter,Clozel, Martine
, p. 951 - 954 (2007/10/03)
Modification of the structure of bosentan 1, the first marketed endothelin receptor antagonist (Tracleer), by introduction of a second sulfonamide function at the alkoxy side chain, led to bis-sulfonamides 2. This allowed to prepare dual ETA/ETB as well as ETB receptor selective antagonists, which could serve as tools to investigate the pharmacological consequences of selective ETB receptor blockade.